A previous study on cancer intrinsic IRE1α-XBP1 signaling in breast cancer employed immunocompromised mice and therefore, did not evaluate the impact of XBP1 loss on the immune microenvironment10. This evidence concerns the gene XBP1 and breast carcinoma.